Retatrutide 20 mg Scientific Background Retatrutide is a synthetic peptide under investigation for concurrent agonist activity at GLP-1, GIP, and glucagon receptors. Ongoing in-vitro studies examine multi-receptor signalling and downstream metabolic pathways. Specification Peptide Name: Retatrutide Content: 20 mg lyophilized powder (requires reconstitution) Purity: ≥ 99 % (HPLC / MS certificate available) Manufacturing: ISO 9001:2015 & cGMP-audited facility Intended Use: In-vitro laboratory research only Storage & Handling Prior to reconstitution: store ≤ 8 °C in a dry environment After reconstitution: refrigerate 2 – 8 °C and use within 30 days Long-term preservation: aliquot and freeze at −20 °C Avoid repeated freeze–thaw cycles Compliance Notice Supplied exclusively to qualified professionals for controlled laboratory applications. No dosage or administration guidance is provided. Buyer assumes responsibility for safe handling and regulatory adherence.